Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 Sep;59(9):213-23.

Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure

Affiliations
  • PMID: 14618198
Clinical Trial

Improvement in exercise performance after successful cardioversion in patients with persistent atrial fibrillation and symptoms of heart failure

Beata Wozakowska-Kapłon et al. Kardiol Pol. 2003 Sep.

Abstract

Background: Loss of atrial systolic function as well as fast and irregular ventricular response result in the impairment of hemodynamic function in patients with atrial fibrillation (AF). AF is considered to be a less efficient cardiac rhythm than sinus rhythm (SR), and accounts for the symptoms of reduced exercise tolerance, such as fatigue, tiredness or dyspnoea. In more severe cases, the hemodynamic alterations can result in heart failure.

Aim: To assess exercise performance before and one month after cardioversion of persistent AF.

Methods: We studied 42 patients with mild to moderate clinically stable heart failure and persistent AF (median duration 7 months) with controlled ventricular rate. They underwent submaximal exercise testing 24 hours before cardioversion and one month after cardioversion. Exercise capacity was determined during symptom-limited exercise testing, according to a modified Bruce protocol with peak VO(2) analysis.

Results: Thirty-five (83%) patients were successfully cardioverted to SR. One month after cardioversion 29 patients remained in SR (SR group) while 6 had recurrence of AF, and, together with patients with unsuccessful cardioversion, formed the AF group (n=13). Baseline patient characteristics did not differ between the SR and AF groups. Left ventricular ejection fraction (52.7+/-10.2% vs 56.5+/-9.6%, NS) and exercise tolerance (peak VO(2) 19.85+/-3.5 ml/min/kg vs 22.2+/-3,4 ml/kg/min, NS; and exercise duration 9.5+/-3.4 min vs 10.6+/-2.4 min; NS) were similar in both groups before cardioversion. Successful cardioversion resulted in a mean decrease in resting heart rate of 28 beats/minute (94.7+/-10.3 vs 66.7+/-9.7 beats/min, p<0.05), measured 30 days after cardioversion, and a significant improvement in exercise tolerance in the SR group: exercise duration increased from 9.5+/-3.4 min to 13.7+/-3.2 min, p<0.05; and peak oxygen consumption increased from 19.85+/-3.5 ml/min/kg to 32.2+/-3.6 ml/min/kg, p<0.05. No improvement was observed in the AF group.

Conclusions: Restoration of sinus rhythm in patients with persistent AF is associated with a significant improvement in exercise capacity one month after cardioversion.

PubMed Disclaimer

Similar articles

Cited by

Publication types